Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in GTBP — GT Biopharma, Inc.

CIK 1000275 TORONTO, A6
Back to GTBP Full portfolio

Position in GTBP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,724
+$3,673 QoQ
Shares Held
304
+5980.0% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 57 holders
Holding Since
Mar 2021
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GTBP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,792,853 across 427 Biotechnology names. GTBP ranks #337 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in GTBP

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,724 7,600
2026-03-31 $51 126
2024-09-30 $11 5
2024-06-30 $19 7
2024-03-31 $31 7
2023-12-31 $559 2,197
2023-09-30 $586 2,436
2023-06-30 $1,190 3,819
2023-03-31 $1,378 2,508
2022-12-31 $249,814 281,958
2022-09-30 $3,639 2,068
2022-06-30 $5,854 1,958
2022-03-31 $8,781 3,049
2021-12-31 $19,448 6,377
2021-09-30 $27,861 4,134
2021-06-30 $55,643 3,590
2021-03-31 $167,865 24,542